1. Home
  2. QNCX vs AHT Comparison

QNCX vs AHT Comparison

Compare QNCX & AHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • AHT
  • Stock Information
  • Founded
  • QNCX 2012
  • AHT 2003
  • Country
  • QNCX United States
  • AHT United States
  • Employees
  • QNCX N/A
  • AHT N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • AHT Real Estate Investment Trusts
  • Sector
  • QNCX Health Care
  • AHT Real Estate
  • Exchange
  • QNCX Nasdaq
  • AHT Nasdaq
  • Market Cap
  • QNCX 44.0M
  • AHT 35.8M
  • IPO Year
  • QNCX 2019
  • AHT 2003
  • Fundamental
  • Price
  • QNCX $1.03
  • AHT $6.06
  • Analyst Decision
  • QNCX Strong Buy
  • AHT
  • Analyst Count
  • QNCX 5
  • AHT 0
  • Target Price
  • QNCX $8.00
  • AHT N/A
  • AVG Volume (30 Days)
  • QNCX 511.8K
  • AHT 24.1K
  • Earning Date
  • QNCX 05-16-2025
  • AHT 05-06-2025
  • Dividend Yield
  • QNCX N/A
  • AHT N/A
  • EPS Growth
  • QNCX N/A
  • AHT N/A
  • EPS
  • QNCX N/A
  • AHT N/A
  • Revenue
  • QNCX N/A
  • AHT $1,143,552,000.00
  • Revenue This Year
  • QNCX N/A
  • AHT N/A
  • Revenue Next Year
  • QNCX N/A
  • AHT N/A
  • P/E Ratio
  • QNCX N/A
  • AHT N/A
  • Revenue Growth
  • QNCX N/A
  • AHT N/A
  • 52 Week Low
  • QNCX $0.51
  • AHT $5.20
  • 52 Week High
  • QNCX $2.45
  • AHT $13.90
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 38.67
  • AHT 43.74
  • Support Level
  • QNCX $0.98
  • AHT $5.63
  • Resistance Level
  • QNCX $1.16
  • AHT $6.36
  • Average True Range (ATR)
  • QNCX 0.09
  • AHT 0.40
  • MACD
  • QNCX 0.01
  • AHT 0.06
  • Stochastic Oscillator
  • QNCX 22.22
  • AHT 51.22

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

About AHT Ashford Hospitality Trust Inc

Ashford Hospitality Trust Inc. is a real estate investment trust that invests in full-service upscale and upper-upscale hotel properties in the U.S. The company owns and operates its assets through its operating partnership, Ashford Hospitality Limited Partnership. All of its hotels are located across the U.S. and operate under the Marriott, Hilton, Hyatt, Crowne Plaza, and Sheraton brands. Ashford's sole segment is Direct Hotel Investments, through which it owns hotels by acquisition or development. Ashford also provides real estate investment services, such as mezzanine financing, first mortgage financing, and sales-leaseback transactions. Its revenue streams include Room revenue, Food and beverage revenue, and Other revenue. Room revenue accounts for the majority of total revenue.

Share on Social Networks: